Oscar Health Signals Upcoming Financial Results Disclosure
Ticker: OSCR · Form: 8-K · Filed: Feb 7, 2024 · CIK: 1568651
Complexity: simple
Sentiment: neutral
Topics: financial-condition, results-of-operations, 8-K
TL;DR
**Oscar Health is about to drop its financials, get ready for potential stock movement.**
AI Summary
Oscar Health, Inc. filed an 8-K on February 7, 2024, under Items 2.02 and 9.01, indicating they will be disclosing their financial results and condition. This filing signals that investors should expect an upcoming announcement regarding Oscar Health's performance, which could significantly impact the stock price depending on whether the results exceed or fall short of market expectations. For shareholders, this means a potential catalyst for stock movement is imminent, while prospective buyers should await the actual financial disclosure to make informed decisions.
Why It Matters
This 8-K signals that Oscar Health, Inc. is about to release its financial performance, which will directly influence investor sentiment and the company's stock price.
Risk Assessment
Risk Level: medium — The risk is medium because the actual financial results are not yet disclosed, creating uncertainty about the stock's future direction.
Analyst Insight
A smart investor would monitor Oscar Health's news releases closely for the actual financial results and consider setting alerts for the upcoming earnings call or report.
Key Players & Entities
- Oscar Health, Inc. (company) — the registrant filing the 8-K
- February 7, 2024 (date) — date of earliest event reported and filing date
- 001-40154 (other) — Commission File Number for Oscar Health, Inc.
- OSCR (other) — trading symbol for Oscar Health, Inc. Class A Common Stock
- New York Stock Exchange (other) — exchange where Oscar Health, Inc. Class A Common Stock is registered
Forward-Looking Statements
- Oscar Health will release its full financial results shortly after this 8-K filing. (Oscar Health, Inc.) — high confidence, target: 2024-02-21
FAQ
What is the purpose of Oscar Health, Inc.'s 8-K filing dated February 7, 2024?
The 8-K filing by Oscar Health, Inc. on February 7, 2024, under Items 2.02 and 9.01, indicates that the company will be disclosing its results of operations and financial condition, along with related financial statements and exhibits.
What is the trading symbol and exchange for Oscar Health, Inc.'s Class A Common Stock?
Oscar Health, Inc.'s Class A Common Stock has the trading symbol OSCR and is registered on the New York Stock Exchange.
What is the address of Oscar Health, Inc.'s principal executive offices?
The principal executive offices of Oscar Health, Inc. are located at 75 Varick Street, 5th Floor, New York, New York 10013.
Is Oscar Health, Inc. considered an emerging growth company according to this filing?
No, the filing indicates with a '☐' that Oscar Health, Inc. is not an emerging growth company as defined in Rule 405 of the Securities Act of 1933 or Rule 12b-2 of the Securities Exchange Act of 1934.
What is the state of incorporation for Oscar Health, Inc.?
Oscar Health, Inc. is incorporated in Delaware.
Filing Stats: 531 words · 2 min read · ~2 pages · Grade level 9.5 · Accepted 2024-02-07 16:13:52
Key Financial Figures
- $0.00001 — hich registered Class A Common Stock, $0.00001 par value per share OSCR New York Stock
Filing Documents
- oscr-20240207.htm (8-K) — 26KB
- oscr-4q23xpressrelease.htm (EX-99.1) — 485KB
- imagea.jpg (GRAPHIC) — 20KB
- 0001568651-24-000004.txt ( ) — 697KB
- oscr-20240207.xsd (EX-101.SCH) — 2KB
- oscr-20240207_lab.xml (EX-101.LAB) — 23KB
- oscr-20240207_pre.xml (EX-101.PRE) — 12KB
- oscr-20240207_htm.xml (XML) — 3KB
02. Results of Operations and Financial Condition
Item 2.02. Results of Operations and Financial Condition. On February 7, 2024, Oscar Health, Inc. (the "Company") announced the Company's financial results for the fourth quarter and year ended December 31, 2023. A copy of the press release issued in connection with the announcement is attached and furnished as Exhibit 99.1 to this Current Report on Form 8-K and incorporated herein by reference. The information in Item 2.02 and Exhibit 99.1 of this Current Report on Form 8-K shall not be deemed "filed" for purposes of Section 18 of the Securities Exchange Act of 1934 (the "Exchange Act"), or otherwise subject to the liabilities of that section, nor shall such information and exhibits be deemed incorporated by reference in any filing under the Securities Act of 1933 or the Exchange Act, except as expressly set forth by specific reference in such a filing.
01. Financial Statements and Exhibits
Item 9.01. Financial Statements and Exhibits. (d) Exhibits . Exhibit No. Description 99.1 Press Release, dated February 7, 2024 104 Cover Page Interactive Data File (embedded within the Inline XBRL document).
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. Oscar Health, Inc. By: /s/ R. Scott Blackley Name: R. Scott Blackley Title: Chief Financial Officer Date: February 7, 2024